2A9-17498-70586
1 vaccination
1 coded response
5 check-ins
1 free-text entry
0 call cases
- Sex
- Female
- Age at first dose
- 31-35
- ZIP prefix
- 223 / VA
- Registered
- 2021-08-15
- Relationship
- Self
- Race
- White
- Ethnicity
- Not Hispanic or Latino
Timeline
-
2021-08-13
Dose 1 — Pfizer-BioNTech
-
2021-08-15
Registered in v-safe
-
2021-08-15
Health check-in — days 1–6 daily, dose 1Feeling: Good · Site: Pain, Redness, Swelling, Itching · NoneAdult check-in
-
2021-08-16
Health check-in — days 1–6 daily, dose 1Feeling: Good · Site: Pain, Swelling, Itching · NoneAdult check-in
- 2021-08-17
- 2021-08-18
-
2022-02-11
Survey response — 6 months, dose 1MedDRA: Premature delivery — Feeling: GoodFree text: Delivered baby prematurely at 34 weeks - 2 weeks after getting vaccine. Healthy pregnancy with no issues up until that point.MedDRA releases: 2024-11 · check-in free text available
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2021-08-13 | Pfizer-BioNTech | No |
Free text
Release 11 — 6 months, dose 1
Symptoms: Delivered baby prematurely at 34 weeks - 2 weeks after getting vaccine. Healthy pregnancy with no issues up until that point.
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SD | Premature delivery | · | · | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release